To define relationships better between the duration of severe ischemia and microvascular functional integrity with an approach potentially applicable to studies in vivo, the effects of 30 and 60 minutes of global, no-flow ischemia on the coronary vascularure of isolated, perfused rabbit hearts were determined. Residue-detection data, analyzed with a two-compartment model, were used to estimate indices of microvascular function, including the mean-transit time ({BSA) of radiolabeled bovine serum albumin ( I25 I-BSA), vascular into extravascular space clearance, and vascular and extravascular space volumes. It was shown that the Central Volume Principle of tracer kinetics does not hold when transport of label between vascular and extravascular spaces takes place convectively by solvent drag, and a more general expression for ?BSA was derived and applied. Left ventricular end-diastolic pressure and left ventricular developed pressure were monitored with an isovolumic balloon. Aortic perfusion pressure, left ventricular end-diastolic pressure, left ventricular developed pressure and vascular space volume remained constant, while mean transit time, vascular into extravascular space clearance and extravascular space volumes increased gradually during 3hour control perfusions. Perfusion pressure, mean transit time and extravascular space clearance increased significantly with reperfusion after 30 minutes of ischemia even though left ventricular end-diastolic and left ventricular-developed pressures returned to control levels. Vascular space volumes increased minimally, whereas extravascular space volumes increased S-fold during reperfusion. These changes in 126 I-BSA washout and permeation across endothelium with reperfusion after no-flow ischemia indicate that compromised vascular integrity is an early manifestation of ischemia with functional consequences that persist even after ischemia sufficiently brief to permit restoration of left ventricular performance. (Circ Res 52: 210-225, 1983) 
DESPITE considerable interest in effects of ischemia on the coronary vasculature (Krug et al., 1966; Kloner et al., 1974 Kloner et al., ,1980 Armiger and Gavin, 19754; Camilleri et al., 1976; Gavin et al., 1978) , the temporal dependence of microvascular injury on the duration of severe ischemia has not been elucidated definitively. External quantification of such sequelae is important in defining candidates suitable for interventions such as coronary thrombolysis and for assessment of their clinical efficacy. Compromised functional integrity of the vasculature has been inferred from light-microscopic and ultrastructural studies in which carbon labeling of vessels was demonstrated after 60 minutes of ischemic injury (West et al., 1978; Fishbein et al., 1979) . Furthermore, leakage of trypan blue and small molecular weight plasma proteins, and augmented cardiac-lymph flow occur after myocardial ischemia in dogs (Meneely, 1974; Feola and Glick, 1975; Gervin et al., 1982) . Although ultrastructural evidence of myocardial injury develops prior to evidence of microvascular injury (Kloner et al., 1980) , implying that the latter may be only a late manifestation, impaired functional integrity of the vasculature may precede morphological changes. The present study was performed to further characterize and quantify changes in microvascular transport function after selected intervals of no-flow ischemia.
Capillary permeability and transport function can be assessed by several physiological techniques (Crone, 1970) . Most employ (1) measurement of transient osmotic effects and diffusion fluxes of test solutes introduced in substantial concentration in the plasma (Pappenheimer, 1953; Vargas and Johnson, 1967; Schafer and Johnson, 1964) , (2) direct measurement of transport rates (multiple indicator-dilution; residue-detection) with test substances present in trace concentration to avoid transient osmotic effects (Crone, 1963; Yudilevich et al., 1968; Alvarez and Yudilevich, 1969; Lassen and Sejrsen, 1971; Paaske, 1976) , or (3) measurement of lymphatic fluxes for large molecular weight tracers (Renkin, 1964; Garlick and Renkin, 1970; Taylor et al., 1977) . The bolusinjection, external-detection technique used in the present study has been employed previously to assess flow and transport across capillary barriers under physiological conditions (Zierler, 1965; Sejrsen, 1979; Paaske, 1976; Raichle et al., 1976; Lassen and Perl, 1979) . Among the advantages of this technique are its simplicity and high temporal resolution, made possible by elimination of venous catheter sampling.
Methods

Perfusion Techniques
Isovolumically beating, isolated hearts from male New Zealand white rabbits (weighing 2-3 kg and heparinized intravenously with 6000 units of sodium heparin 10 minutes prior to sacrifice) were perfused retrograde via the aorta at a paced rate of 180-200 beats/min with modified Krebs-Henseleit buffer (KH) containing 1% dialyzed bovine-serum albumin (BSA), 0.5% dialyzed polyvinylpyrrolidone (PVP; mol wt = 360,000), 2 nw pyruvate, 8 miu dextrose, and 25 mM bicarbonate. KH buffer was filtered through 0.45-jum Gelman mini-capsule filters, warmed to 37°C (monitored with thermistor probes), and oxygenated at pH 7.4 by dialysis against 95% O 2 :5% CO2 across Silastic tubing (0.058" i.d. by 0.077" o.d.; Dow-Corning). Perfusate pH, Pco2, and P02 were monitored with a blood gas analyzer (Instrumentation Laboratory, Inc.) . Hearts were rinsed with KH buffer without BSA or PVP at 37.0 ± 0.5°C. The tricuspid valve was rendered incompetent and a pulmonary artery cannula inserted into the right ventricle was connected to a gravity-fed reservoir containing KH buffer (37°C and pH 7.4) for rinsing the right side of the heart. Hearts were perfused apex-up in an Oak-Tree Instruments apparatus and were supported with an apical suture connected to the balloon in the left ventricle. Hearts were rinsed continuously over the surface and through the right ventricle and atrium to facilitate rapid removal of tracer that had passed through the coronary vasculature.
Iodination of Bovine Serum Albumin (BSA)
Twenty milligrams of purified BSA (Sigma) in phosphate-buffered saline were iodinated in a 20-minute interval with 1 mCi 125 I at 37°C, pH 7.0, by the lactoperoxidase method (Marchalonis, 1969; Krohn and Welch, 1974) , quenched with 0.1 M cold KI, and 125 I separated from 125 I-BSA by chromatography on Sephadex G-25. 125 I-BSA fractions were pooled, dialyzed against KH buffer (pH 7.0, 4°C), filtered through 0.2-jum Acrodisc filters (Gelman Sciences), and vacuum concentrated with the use of collodion bags having a 25,000 molecular weight cut-off (Schleicher and Schuell). Homogeneity of 125 I-BSA and a free 125 I content of less than 0.3% were verified with isoelectric focusing and gel electrophoresis.
Experimental Protocol
Nonischemic control hearts were perfused continuously for 3 hours; ischemic hearts were perfused for 1 hour prior to global, no-flow conditions for 30 or 60 minutes, then were reperfused at the same baseline flow rate for 90 or 60 minutes, respectively. During no-flow periods, heart temperature was maintained at 37°C with a heat lamp and surface rinses. Every 15 minutes, perfusion pressure, left ventricular end-diastolic pressure (LVEDP), and left ventricular (LV)-developed pressure were recorded with P23Db Statham pressure transducers and a Gould recorder. A 25-fi\ bolus of 125 I-BSA in KH, pH 7.0, was injected into the proximal aorta near the coronary ostia with a Hamilton syringe. Residue-detection data were acquired as previously described (Raichle et al., 1976) and stored on floppy disks for subsequent analysis with Hewlett-Packard 1000L and IBM 370 computers. Sampling times were for 0.5 second in the initial portion of each recording.
In some experiments, 14 C-sucrose in KH buffer was perfused during the terminal 5 minutes. After perfusion, hearts were removed rapidly, rinsed with saline, trimmed, blotted dry, weighed, and sectioned (8 to 10 transmural LV sections) prior to assay of 14 C radioactivity by scintillation spectrometry. Perfusate radioactivity was assayed similarly. Selected transmural LV sections were dried to constant weight at 70°C for determination of water content.
Liquid Scintillation Data Analysis
Data were analyzed with a Hewlett-Packard 9845T desktop computer. Counting efficiency as a function of increasing quench was determined and tracer activity was corrected accordingly. The 14 C-sucrose volume of distribution per g wet weight (V suc ) was calculated using V suc = C su<: (heart) C suc (perfusate)'
U)
where C suc (heart) and C suc (perfusate) are, respectively, the specific sucrose activities in each piece of heart (counts/min per g wet weight) and in perfusate (counts/min per ml KH buffer). Results of tissue assays were converted into ml/g dry weight, and these data, together with estimates of vascular space derived from the two-compartment model analysis of residue-detection data, were used to estimate the specific extravascular space (V 2 ) for calculations of convective transport.
Mathematical Model
Although mathematical models have been employed to assess vascular flow and transport phenomena under physiological conditions, they have not been widely utilized to examine perturbations in microvascular function induced by ischemia. The pronounced variations observed in the shapes of the externally monitored residue curves in the present study imply sensitive dependence of ultrastructural determinants of albumin transport on ischemic injury and the possibility of drawing inferences regarding the extent and nature of such injury from altered transport behavior as reflected in the residue curves. It appeared advantageous to interpret the residue data quantitatively, using a mathematical model incorporating a detailed description of tracer transport at the microvascular level, and the clearly biexponential character of the kinetic curves suggested a twocompartment model. Accordingly, the uptake and clearance of I-labeled albumin in these heart preparations were interpreted with a model (Fig. 1 ) describing temporal changes of radiolabeled tracer distributions due to transport of label within the vasculature and between the vascular and extravascular spaces. Movements are interpreted in terms of diffusive-and convective-transport mechanisms operating simultaneously within a hypothetical membrane (of assumed negligible tracer content) separating albuminaccessible vascular and extravascular spaces. These effects are related by the model to the history of total radioactivity registered externally. No specific morphological identity is assigned to the membrane. The model parameters and their numerical estimates from the experimental data represent global averages. No assumptions are made concerning the distribution of the number of radioiodine atoms on labeled albumin molecules other than that the mean of the distribution remains unchanged locally while tracer traverses the heart. The detector response depends on total amounts of radioiodine in its field of view at any instant; spatial uniformity of detection efficiency is assumed.
Components of the model and mathematical derivations are described in the Appendix. Only the principal mathematical results used to interpret the experimental data are provided here. Conventional requirements are assumed to FIGURE 1. Model for analysis of data obtained in the measurements of radioalbumin transport in heart preparations before and after ischemic injury. Subsystems labeled 1 and 2 are assumed to be vascular and extravascular radioalbumin compartments, respectively; the corresponding volumes of distribution are V t and V2. System surroundings are labeled 0. The external radiation detector field of view is represented by the interior of the curve enclosing the two compartments. Convective arterial and venous fluxes of radioalbumin entering and leaving the field of view are denoted by j m(t) and joi (t), respectively. Time, t, is measured from the start of tracer injection. Unidirectional intercompartmental fluxes are denoted by J2\(t) and jii(t); directions of transport are shown by arrows. For i = 1 or 2, q,(t), ci(t), and at(t) represent, respectively, radioalbumin amount, concentration, and thermodynamic activity in compartment i as a function of time. The symbol y, denotes the thermodynamic activity coefficient of albumin in compartment i. Compartmental turnover-rate constants, £,y (i ¥> j; i -0, 1, 2; j = 1, 2) are fractions of radioalbumin or of albumin in compartments j that are transported per unit time into compartments i. hold for the validity of tracer stimulus-response methods concerning stability and linearity (Perl, 1971) . Although certain of the model parameters describing albumin transmembrane mass-transport conductivities change continuously during reperfusion after ischemia, the stability requirement is satisfied reasonably well because the interval over which a tracer response curve is monitored is small relative to the duration of ischemia and reperfusion.
With the use of a parameter-estimation technique described below, the biexponential function
is fitted to the experimental residue count-rate data. Here, t represents time elapsed after the instant the maximum count rate is observed following injection of the radiotracer bolus. The symbols Ai, A 2 , «i, and a&> represent adjustable parameters. In the Appendix, it is shown that these parameters are related to the compartmental turnover-rate constants of the model, km, k i2 and k 2 i ( Fig. 1) according to km = a, -(«] -a 2 )A 2 /r 0 = a 2 + (a, -a 2 )A,/r 0 , and (a, + a 2 ) -(koi + k 12 ), where r 0 A r(t = 0), i.e., the peak count rate, whose instant of occurrence defines zero time. The identity in Equations 3 follows from the constraint Ai + A 2 = ro, which can be seen to hold on putting t = 0 in Equation 2. The ky in Equations 3 to 5 represent the fraction of the mass of tracer in compartment j that is transported, per unit time, into compartment i. Here, subscripts 1 and 2 denote, respectively, vascular space and extravascular space accessible to albumin; 0 denotes the surroundings external to both compartments 1 and 2. An interpretation of the compartmental turnover-rate constants that relates them to the perfusate flow, to the compartmental albumin space, and to the practical membrane-transport coefficients (Kedem and Katchalsky, 1961; House, 1974; Perl, 1975) In the above, P is the surface area-averaged permeability coefficient, S is the total membrane surface available for permeation, J v is the net systemic fluid-filtration volume flow, a is the filtration flow-averaged solvent-drag reflection coefficient (Perl, 1975) , Vi is the vascular compartment volume, V 2 is the extravascular albumin compartment volume, and yi is the thermodynamic activity coefficient of albumin in compartment i, for i = 1, 2. The volume flow, J v , is driven by an average pressure drop, due to combined hydraulic and osmotic effects, from compartment 1 to compartment 2. Simultaneous solution of Equations 7 nd 8 yields PS = fc(F 2 , + F 12 )/y
for the permeability coefficient surface-area product and and U A tyla)J v F 21 -y,F I2 )/y7 (10) in which we have defined the ultrafiltration parameter, U. For the above, we further define the unidirectional clearances (Perl, 1975) as and with F 2 , 4 y,PS + U = k 2 iV, F 12 A y 2 PS -U = k 12 V 2 ,
Equations 6 to 12 pertain to a single heart preparation whose weight, on a dry basis, is W. To allow comparison of results between preparations of different sizes, values of the global parameter estimates are computed and reported relative to the dry weight. Accordingly, normalized parameters are defined; these, with their units, are
F21 A F 21 /W (cmVsec per g), 
in which W has the dimension of g. The qualifier "specific" is applied to indicate this normalization. On combining Equations 6-12 with 14-21, the relations 
are obtained. Thus, the dimensions of the ky (per sec), are unchanged by the normalization procedure. The permeability coefficient, P, has dimensions of cm/sec. As shown in the Appendix, its definition in terms of albumin flux and albumin thermodynamic activities is such that its units are independent of W. The reflection coefficient, a, and the activity coefficients, yi, Y2, and y, all being dimensionless by definition, are also independent of W.
Parameter Estimation
Parameter estimation was accomplished with the approach described by Markham et al. (1976) , utilizing an algorithm based on maximum-likelihood estimation procedures for Poisson-distributed data developed by Sandor et al. (1970) , Wilson (1972), and Snyder (1973) . To our knowledge, the present work represents the first application of this approach in a detailed tracer-kinetic study. For the present radioalbumin count-rate data, the method was implemented by maximizing the Poisson-distribution likelihood function having the biexponential intensity specified by Equation 2. This provided estimates Ai, A 2 , a i, and a 2 of the parameters Ai, A 2 , a\, and a 2 of the intensity function. These estimates were used in Equations 3-5, assuming stochastic independence of the variates, to obtain estimates of the turnover-rate constants in the forms ko. = 
where the estimate ?o = ro has been employed. In turn, the above estimates were used in Equations 22 and 23, again assuming stochastic independence, to obtain estimates for specific vascular volume and for the specific forward unidirectional clearance, respectively, as V, F/ko, and as , 1977) .
Approximate starting values for the parameters of the intensity function (Eq. 2) used in the iterative calculations of the maximum-likelihood parameter-estimation method of Markham et al. (1976) were obtained by least-squares fits of 125 I-BSA residue curves through use of "peeling" techniques (Simon, 1972) . Initial approximations of the maximum-likelihood estimates were obtained that were sufficiently close to provide satisfactorily rapid convergence.
In the Appendix, it is shown that the mean of the distribution of radioalbumin transit times, tBSA, is related to the parameters of the intensity function of the model, Equation 2, by FBSA = [(A,/a,) -1-(A 2 /a 2 )]/r 0 .
(35; A-44) Accordingly, the form for the estimate of tBSA, assuming stochastic independence of the parameters involved, is
In the Appendix it is further shown that the albumin mean transit time is given in terms of the diffusive-and convective-transport parameters as
The corresponding form for the estimate of tBSA in terms of estimates of the parameters normalized to dry weight is obtained from the above two equations in the form with an estimate of p given by p = U/(PS).
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Statistical Analysis
Within Runs From initial estimates of variance for F, W, and r<j, and from those computed by the maximum-likelihood algorithm of Markham et al. (1976) for the four parameters of the intensity function (2), variance estimates were computed for each of the derived physiological parameters using the theory of error propagation (Eadie et al., 1971) . Standard deviations for these parameters were obtained as the positive square roots of the corresponding error-propagation variances. As in the case of the physiological parameters, estimates of variance and standard deviation for t BSA were obtained using error-propagation theory, again assuming stochastic independence of the parameters.
Between Runs
Means ± SD, as well as ± SEM (for data presented graphically only) were calculated for each parameter assessed for controls and ischemic groups at each perfusion time interval. Student's t-test was used to assess significant differences between nonischemic controls and ischemic hearts. Student's t-test for paired observations was utilized to evaluate significant differences between baseline values (mean ± SD of three recordings obtained at 30, 45, and 60 minutes of perfusion) and values obtained during reperfusion within each group of ischemic hearts.
Results
Heart Weight, Water Content, and Flow Rate
Heart weight (~1.0 g dry weight) and baseline perfusate flow rates (~20.6 ml/min per g dry weight) did not differ significantly between hearts in the three groups (Table 1 ). The water content of hearts reperfused following 30 and 60 minutes of ischemia was significantly increased (F<0.005) compared to that of nonischemic control hearts or nonperfused hearts (3.44 ± 0.29 ml H 2 O/g dry weight; P <0.001).
Physiological Data
Nonischemic Control Hearts
Perfusate pressure (Table 2 ) was adjusted to 40 torr at the beginning of each experiment and remained constant except for a slight increase evident during the last hour of perfusion. LVEDP, adjusted to 5 torr by filling the LV balloon with saline, and LV-developed pressure, which averaged 85.5 ± 10.9 torr during baseline, remained constant. Mean values ± SD; n = number of rabbit hearts evaluated for each time interval. Left ventricular (LV) end-diastolic pressure (LVEDP) and LV developed pressure were measured from an isovolumic balloon placed in the left ventricle. Developed pressure was calculated as LV end-systolic pressure minus LVEDP, and was used as an index of maximal heart contraction.
* Baseline denotes average of three recordings taken during the first hour of perfusion.
Ischemic Hearts
No significant differences were evident in baseline perfusion pressure (~40 torr) compared to values in controls ( Fig. 2 ). After global, no-flow ischemia for 30 minutes, reperfusion for 1 minute was associated with a perfusion pressure significantly lower than baseline (P <0.001) and lower than values at comparable intervals in controls (P <0.001). Reperfusion for 15 minutes led to a return of perfusion pressure to values in nonischemic hearts; during more prolonged reperfusion, pressure climbed to levels 64% above control values after 90 minutes. Perfusion pressure was significantly increased at all intervals during reflow in hearts subjected to 60 minutes of ischemia.
LVEDP remained near 5 torr for the entire 3-hour perfusion interval in controls ( Fig. 3 values by 90 minutes of reperfusion. After 60 minutes of global, no-flow ischemia, elevation of LVEDP persisted throughout the entire reperfusion interval. Baseline LV developed pressure for all hearts averaged 86 torr ( Fig. 4) , dropping promptly to 0 with no-flow ischemia. During reperfusion after 30 minutes of no-flow ischemia, developed pressure recovered to 68% (58.8 ± 23.8 torr) of baseline within 30 minutes and to 88% (76.0 ± 9.9 torr) of baseline within 90 minutes of reperfusion. After 60 minutes of no-flow ischemia, recovery of developed pressure was minimal by 15 minutes of reperfusion (9.3 ± 6 . 7 torr) and actually deteriorated with more prolonged reperfusion.
Time-Activity Curves
Time-activity curves (Fig. 5 ), generated after each 25-jul bolus injection of I-BSA into the proximal aorta, exhibited peak activity as radiolabeled albumin entered the coronary circulation and a rapid decrease in activity as 125 I-BSA was cleared from the coronary vasculature. The terminal portion of the curves exhibited monoexponential disappearance of activity background over several minutes. Representative portions of normalized residue-detection curves for 125 I-BSA are shown for control, as well as for 30-and 60-minute no-flow hearts, in Figures 6, 7, and 8, respectively.' The data have been normalized to the peak count rate, ro, and are plotted for times during which the count rates decrease to 1% of their peak values. Baseline recordings for all hearts are similar. No significant changes in the shape of the residue-detection curves are evident throughout the perfusion interval in controls ( Fig. 6 ). After 30 minutes of no-flow ischemia and 1 minute of reperfusion, no change is evident (Fig. 7) . Beginning 15 minutes after onset of reperfusion, the normalized back-extrapolated intercept, A 2 A A2A0 (see Appendix), increases progressively as a function of the duration of reperfusion. After 60 minutes of no-flow ischemia and 1 minute of reperfusion, the monoexponential intercept (A2) is markedly increased (Fig. 8 ), continuing to increase as a function of the duration of reperfusion. After 60 minutes of reperfusion, ~20% of the injected tracer (vs. <1% at baseline) is accounted for by the area under the monoexponential portion of the washout curve.
The mean transit times of albumin (TESA) for controls and during reperfusion after 30 and 60 minutes of no-flow ischemia are shown in Figure 9 . Baseline TBSA for nonischemic hearts averaged 5.2 seconds and increased as a function of perfusion to ~6 seconds after 3 hours. After 30 minutes of no-flow ischemia and 15 minutes of reperfusion, TBSA began to increase, r ;
• -i } '«iBSA ; 1 2 1 2 3 H 5 6 1 2 3 4 5 6 7 DURATION |Min) FIGURE 8. Representative ' 2!> I-BSA external-detection recordings normalized to r 0 , obtained from a single rabbit heart during baseline and reperfusion following 60 minutes of global ischemia. Washout rate of tracer is significantly prolonged by 7 minute and continues to decline for the entire duration of reperfusion.
reaching 13 seconds after 60 minutes of reperfusion. Immediately after the onset of reperfusion (~1 minute) in 60-minute no-flow ischemia hearts, TBSA increased 2.4-fold over baseline. Values increased to 25 seconds after 60 minutes of reperfusion.
Compartmental-Model Analysis
Tracer turnover-rate constants (koi, ki2, k^), specific vascular (Vi), and extravascular space (V2) volumes, and 125 I-BSA forward unidirectional clearance (F21) during 3-hour control perfusions are shown in Table 3 . Baseline values for the rate constant koi averaged 0.431 ± 0.059/sec and remained constant throughout the perfusion interval. 125 I-BSA turnoverrate constants k2i (from vascular into extravascular space) and ki2 (from extravascular into vascular space) across the endothelial barrier were similar under baseline conditions. While ki2 remained constant, k2i increased significantly during the last 2 hours of per-2 5 1 20- 10) ; open triangles, 30 minutes of ischemia (n = 9); solid triangles, 60 minutes of ischemia (n = 6). Student's t-test: * denotes P < 0.001, ** denotes P< 0.005. 
-
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Mean values ± SD; n = number of rabbit hearts evaluated for each interval. * ml/g dry weight; V| = specific vascular volume; V2 = apparent specific extravascular distribution volume, calculated using the Central Volume Principle as V2 = FTBSA -V].
110" 3 ml/sec per g dry weight.
X Baseline denotes average of three recordings during the first hour of perfusion. § P < 0.05; \\P < 0.025; 1|P < 0.001 (compared to baseline values; Student's t-test for paired experiments).
fusion. Vi averaged 0.78 ± 0.16 ml/g dry weight during baseline and remained constant during the 3hour perfusion interval. V2 was nearly equal to Vi during baseline but gradually increased to 1.39 ± 0.86 ml/g dry_weight with perfusion for 3 hours (72% increase). F21 averaged 0.0032 ml/sec per g dry weight at baseline and increased 85% during subsequent perfusion. Tables 4 and 5 present koi, k.12, k2i, Vi, V2, and F21 values for the 30-and 60-minute no-flow hearts. No significant baseline differences were evident for control, 30-minute, or 60-minute no-flow hearts. Reperfusion of 30-minute no-flow hearts was not associated with any change in koi (the rate at which tracer was cleared from the coronary vasculature), or in ki2 or Vi. On the other hand, k2i increased 4-fold and V2 and F2] increased 5-fold after 90 minutes of reperfusion. Reperfusion of 60-minute no-flow hearts resulted in a small but significant decrease in koi and highly significant increases in ki2, k2i, V2, and F21.
Estimates of Diffusive and Convective Transport Parameters for Albumin
Estimates of diffusive (PS; Eq. 33) and convective (U; Eq. 34) transport parameters for 125 I-BSA based on estimates of Vi and V2 obtained from external detection and from equilibrium data at the termination of selected perfusions indicate that permeation of the vasculature by 125 I-BSA at the end of 3-hour control perfusions is accounted for entirely by diffusive transport (Table 6 ). By completion of 90 minutes of reperfusion after 30 minutes of ischemia, PS was nearly three times that of control hearts, and 16% of the total amount of albumin permeating the vasculature could be accounted for by convective transport. After 60 minutes of reperfusion of 60-minute noflow ischemia hearts, PS was over five times that of controls, and 26% of total albumin transport across the vasculature was accounted for by convective transport.
Discussion
Reversible impairment of myocardial contractile function during and after 30 minutes of global ischemia, and irreversible impairment after 60 minutes of ischemia, are consistent with previous observations. On the other hand, the loss of vascular functional integrity in hearts with virtually normal LV Mean values ± SD; n = number of rabbit hearts evaluated for each interval. * ml/g dry weight; Vj = specific_vascular volume; V2 = apparent specific extravascular distribution volume, calculated using the Central Volume Principle as V 2 = FTBSA -Vi. f 10~3 ml/sec per g dry weight.
% Baseline denotes average of three recordings during the first hour of perfusion. §P < 0.01; ||P < 0.005; HP < 0.001 (compared to baseline values; Student's t-test for paired experiments). developed pressure during reperfusion after 30 minutes of no-flow global ischemia has not been reported previously.
The observations in these experiments that the mean transit time of 125 I-BSA, TBSA/ increases markedly during reperfusion following ischemia and that such externally detectable changes can be employed to characterize microvascular function, have several implications. Since flow was maintained constant, increased TBSA could result from: (1) an increase in the volume of distribution (either vascular or extravascular) of 125 I-BSA, or (2) an increase in the ratio of convective to diffusive permeation of I25 I-BSA across the walls of the vasculature (Eq. 37). Abnormal binding of 125 I-BSA to tissue constituents or "no-reflow" as a consequence of ischemia could also increase TBSA-If either of the latter two mechanisms was the main factor responsible for increased TBSA, however, the slopes of the tails of the washout curves should be less than those in control hearts. From visual examination of the curves (Figs. 7 and 8) , it is clear that the slopes are in fact steeper relative to controls (Fig. 5 ). In addition, the intercepts, A2, of the tails of the ischemic washout curves are greatly elevated. Thus, a smaller fraction of injected tracer is confined to the vascular space in hearts reperfused after ischemia, and the major factor accounting for the increased TBSA is an increased ratio of convective to diffusive per- 3.69 ± 1.28 12.11 ± 7.43 * Diffusive-and convective-transport parameters were calculated from Equations 33 and 34 utilizing estimates of Vi derived from two-compartment model data fitting and estimates of V 2 obtained by subtraction of Vi from the sucrose space determined at the end of perfusion. Mean values ± SD; n = number of rabbit hearts evaluated. f 10~3 ml/sec per g dry weight of heart. meation of the vasculature by albumin. This interpretation is supported by estimates of F21 and by electronmicroscopic studies documenting endothelial degeneration with gaps between cells in hearts reperfused after 1 hour of ischemia. Similar ultrastructural changes, which would increase total pore area available for both diffusive and convective transport, also occur in hearts subjected to 30 minutes of ischemia, albeit much less frequently. Two additional considerations also argue against the likelihood that "no-reflow" is responsible for prolonged washout of albumin in this model of ischemia. Since overall perfusion flow rate was held constant, any changes in albumin washout caused by regional alterations in flow would be balanced, theoretically, by changes in albumin washout in the opposite direction resulting from compensatory changes in perfusate flow in the remainder of the heart. It is also unlikely that LV developed pressure would recover to 88% of baseline in 30-minute no-flow ischemia hearts if appreciably more than 12% of the heart were deprived of blood flow. The possibility that increased contractile function in perfused areas of the heart might compensate for loss of contractile function in areas of "no-reflow" cannot be excluded.
Estimates of Diffusive (PS) and Convective (U) Transport Parameters* after 3 Hours of Perfusion
Although "no-reflow" can be virtually excluded as the explanation for the increased TBSA in these experiments, the evidence supporting that conclusion does not argue against the possibility that a reduction in (functional) vascular cross-sectional area might contribute to the increases observed in perfusion pressure. A number of pathophysiological alterations associated with ischemia might tend to reduce vascular cross-sectional area, including endothelial cell swelling (Kloner et al., 1974; Armiger and Gavin, 1975) , vascular plugging by cell debris and/or thrombi, vascular contracture (Krug et al., 1966; Grayson, 1968) , and compression of vessels by edematous myocytes (Hauschild et al., 1970) or myocardial contracture (Humphrey et al., 1981) . It is of interest that no correlation was evident between increases in LVEDP (which-depending on the mechanism responsible for the increased LVEDP-might compress vessels, especially subendocardial vessels, causing an increase in perfusion pressure) and increases in perfusion pressure. Indeed, perfusion pressure increased while LVEDP fell during the last 75 minutes of reperfusion. Thus, it appears unlikely that increases in perfusion pressure during reperfusion after 30 minutes of noflow ischemia were caused by elevated LVEDP.
On the other hand, observations by Willerson et al. (1977) that 40 minutes of coronary occlusion in dogs does not preclude coronary dilation by adenosine or nitroglycerin despite abnormal fluid retention, coupled with unpublished observations of our own that both diltiazem and hyaluronidase reduce perfusion pressure changes by 50% without altering increases of F 2 i with reperfusion, suggest that the increased perfusion pressure observed in 30-minute noflow hearts may be due, at least in part, to vasoconstriction. In view of the possibility that increased perfusion pressure might increase convective transport of albumin, it is of interest that, after 15 minutes of reperfusion, when perfusjon pressure had returned to baseline values, IBSA and F21 were already increased significantly.
Whereas the observation that, at all intervals during reperfusion of 60-minute no-flow ischemia hearts, increases in LVEDP exceeded increases in perfusion pressure (relative to baseline) is consistent with the possibility that vascular compression may contribute to increased perfusion pressure, the finding that perfusion pressure continued to rise while LVEDP decreased slightly suggests that other factors contributed to increased perfusion pressure. The important implication of these observations is that the functional cross-sectional area of the vasculature is reduced during reperfusion after 30 minutes of global, no-flow ischemia, and is reduced still further after 60 minutes of ischemia. The extent to which this reduction is caused by vascular contracture, compression by external pressure, endothelial swelling, and/or vascular plugging by debris was not resolved in these studies.
The microvasculature would be most susceptible to a reduction in vascular cross-sectional area by any of the above mechanisms. This reduction would increase resistance to flow which, in turn, would produce the observed increase in perfusion pressure (since flow rate was held constant), and would tend to dilate the proximal vasculature, possibly accounting for the 50% increase in estimates of Vi during reperfusion after 60 minutes of no-flow ischemia. In addition to increasing perfusion pressure, this reduction in crosssectional area would increase perfusate flow velocity through patent vessels which might cause further vascular damage (by fluid shear forces on the vessel wall).
In light of these considerations, it appears that 30 minutes of no-flow, global ischemia leads to: (1) a reduction in functional vascular cross-sectional area manifested by increased perfusion pressure, (2) compromised functional integrity of the vascular evidenced by increased I2S I-BSA permeation; and (3) an increase in extracellular fluid volume. If contractile performance is impaired in these hearts, it must be regional in distribution and reasonably well compensated for by increased contractile force generated by intact myocardium. Following 60 minutes of no-flow ischemia, damage to both the vasculature and the musculature of the heart is much more severe.
Assessment and Interpretation of Residue-Detection Data with a Two-Compartment Model
Nonischemic Control Perfusions Two-compartment model analysis of residue-detection data requires that enough tracer escape the vascular space to be measured accurately. That this condition holds in the current experiments was demonstrated by the two distinct linear components of the semilog plot of the 125 I-BSA washout curve. Tracer confined to the vascular space washed out rapidly and accounted for approximately 98% to 99% of the injected bolus of radiolabeled tracer in nonischemic hearts. The 1% to 2% of tracer not confined to the vascular space washed out much more slowly, producing the monoexponential tail of the time-activity curve. Moreover, the adequacy of the biexponential function (Eq. 2) for fitting the residue data demonstrates that a single extravascular compartment suffices for modeling the transport behavior of albumin in these preparations.
The deduction from the model that diffusive transport accounts for virtually all outward transport of albumin across the vessel wall at the end of control perfusions is consistent with Perl's prediction (1975) that diffusive transport is the major mechanism by which plasma constituents permeate the capillary bed. If convective transport of albumin also occurs, it is too modest to be measurable by the experimental methods used.
Estimates of Vi derived from fitting the two-compartment model to residue-detection data indicate that under baseline conditions the weight of vascular fluid was 15% of total heart weight. This value, which was calculated with the use of an average baseline value for Vi of 0.77 ml/g dry weight (Tables 3-5), a heart weight of 5.15 g based on 80% water content after 60 minutes of perfusion (unpublished observations), and an average dry weight of 1.03 g (Table 1) , is consistent with the extensive vascularity of cardiac tissue. Estimates of Vi and V2 obtained under baseline conditions (i.e., during the first hour of perfusion) and estimates of Vi throughout the 3-hour control perfusion interval are in good agreement with recent data by Gonzalez and Bassingthwaighte (unpublished) in intact animals, attesting to maintenance of vascular integrity. Observations that perfusion pressure, LVEDP, and LV developed pressure [as well as fractional rate of tracer clearance from the vasculature (koi)] remained constant, attest to the stability of the inverted, perfused heart preparation during the 3hour perfusion interval. Â The ~60% increase in V 2 and the 2-fold increase in F21 over baseline values during the 3-hour control perfusions could be accounted for by pressure gradients across vessel walls without any change in vascular porosity per se. Since neither volume flow, J v , nor pressure gradients were measured during the course of these experiments, it is not possible to assess the relative contribution of these factors in increasing V 2 aijd F 2 i. On the other hand, the finding that V 2 and F 2 i plateaued during the last hour of perfusion suggests that if the increases in f 2 i observed during the first 2 hours of perfusion were due to vascular damage, the injury was not progressive. The finding that ki 2 , the turnover-rate constant for permeation of albumin from extravascular space back into the vascular space, does not increase in parallel with k 2 i is consistent with the finding that V 2 increases during the course of these perfusions, whereas Vi remains relatively constant.
Perfusions after Ischemia
Following ischemia, transport of water is increased as evidenced by the increased V 2 and total water content of hearts. The marked increase in outward movement of albumin by convection (presumably because of increased porosity of the vessel wall), accounted for 26% of total transport of albumin across the vasculature in 60-minute no-flow ischemia hearts reperfused jbr 60 minutes. The finding that increases of k 2 i and F21 are much greater during reperfusion of 30-minute no-flow ischemia hearts than in controls and the even greater increases in these parameters in the 60-minute no-flow ischemia hearts are consistent with ultrastructural evidence of endothelial injury. The observations that: (1) after 90 minutes of reperfusion of 30-minute no-flow ischemia hearts, Vi inc/eased by 13%, and (2) after 60 minute of reperfusion Vi increased by 50% in 60-minute no-flow ischemia hearts, are consistent with vasodilation as discussed above.
The observation that estimates of Vi + V2 obtained at the end of 60 minutes of reperfusion of 60-minute no-flow ischemia hearts equalled or exceeded total water content determined gravimetrically (7.17 vs. 6.83 ml/g dry weight, respectively, Tables 1 and 5) indicates a limitation in applying the Central Volume Principle to the determination of V 2 from measured perfusate flow and TBSA. This is because the Central Volume Principle assumes tracer transport by diffusion only (see Appendix), whereas, after 60 minutes of ischemia, convective transport accounts for a significant fraction of total tracer transport.
In conclusion, the present findings indicate that ischemia-induced changes in vascular permeability barriers to albumin can be assessed sensitively in isolated perfused rabbit hearts with the use of external-detection techniques. Significant increases in albumin permeation with reperfusion after 30 minutes of ischemia, in the face of virtually normal LV-developed pressure, suggest that microvascular functional integrity is markedly impaired by relatively brief intervals of severe ischemia.
Appendix
Tracer Conservation Conditions
Under the assumptions of the compartmental modeling approach discussed in the text, tracer conservation conditions in compartments 1 (vascular space) and 2 (extravascular albumin space) take the forms i^K q(t) = jo(t), t > 0 (A-l)
In the above, q(t) = (qi(t)}f_i is the vector of tracer masses, jo(t) = {jio(t)}?_i is the vector of external tracer-input rates, I is the identity matrix, and K = [/Cij] is the matrix of turnover-rate constants. The elements of K are the physiological significance we ascribe to the individual rate constants, kij, are discussed below. Since the time course of the tracer-administration rate is sufficiently rapid that the entire bolus of radioalbumin is initially present within the field of view of the external detector, we model this time course as an idealized impulse. Thus, we specify jio(t) = qo5(t + 0), in which qo is the mass of radioalbumin in the bolus and 8(t + 0) is the unit-impulse function, for which we define the property J ™ S(t + 0) dt = 1. We assume that the only way tracer can enter and leave the detector field through the preparation is by carriage in flowing perfusate; hence j 2 o(t) = 0 and J02(t) = 0 for t 2 0. Thus, the input vector is jo ( Equation A-7 gives the Laplace transforms of the amounts of tracer in each compartment, qi(t) and q 2 (t), respectively. According to the assumptions discussed in the text a single external-radiation detector cannot resolve these two components. Instead, it registers a count rate proportional to the total amount of radiotracer in its field of view. This total is the sum, or residue (Zierler, 1965) , given by q(t) = qi(t) + q 2 (t), t > 0. 
External-Detector Response Function
To relate the detector response, r(t), to the amount of radioalbumin in its field of view at time t, we define detection coefficients as €i 4 ri(t)/ qi (t), t > 0, i = 1, 2.
(A-16a,b)
Under the assumptions discussed in the text, the e, are temporally invariant, and further, £i = e 2 = £• Then, by Equations A-8 and A-16, we have r(t) = r,(t) + r 2 (t) = eq(t), t > 0.
(A-17) Ai = (koi -« 2 )/(ai -a 2 ) (A-15a)
On combining Equations A-14 and A-17, we find the external-detector count rate to be r(t) = '"*', t > 0, (A-18;2) where i A r 0 Ai, i = 1, 2, (A-19a,b) and where r 0 4 r(t = 0) = eqo (A-20) is the external-detector count rate due to the amount q 0 of radioalbumin initially present within its field of view.
Compartmental Turnover-Rate Constants
The compartmental turnover-rate constants can now be derived from the parameters of the observed detector count rate as follows. From Equations A-15 and A-19, we obtain koi = «i -(«i -« 2 )A 2 /ro (A-21a;3a) = <x 2 + (ai -a 2 )Ai/r 0 , (A-21b;3b) and from Equations A-13, ki2 = aia 2 /k O i (A-22;4) and k 2 i = (ai + a 2 ) -(koi + k 12 ). (A-23;5)
We evaluate k J2 and k 2 i from the Ai and the a* stepwise, using koi from Equations A-21 in Equations A-22 and A-23 and ki 2 from Equation A-22 in Equation A-23.
Physiological Interpretation of the Turnover-Rate Constants The convective flux of radioalbumin leaving the detector field by carriage in flowing perfusate via the venous outflow of the preparation is joi(t) = Fcv(t), where F is the total perfusate flow and cv(t) is the flow-averaged radioalbumin concentration in the perfusate at the venous outflow. An assumption of the compartmental approach, as applied here, is that radiotracer concentration gradients are negligible everywhere within the albumin spaces Vi and V2. Thus, c v (t) = ci(t) = qi(t)/Vi, and therefore joi(t) = koiqi(t) all hold, where we define the convective turnover-rate constant koi 4 F/V,.
(A-24; 6)
The net radioalbumin flux from the vascular to the extravascular spaces, j(t), can be expressed as the sum of a diffusive flux, ja(t), and a solvent-drag convective flux, j c (t) (Perl, 1975) The parameters P, S, a, and J v are defined and discussed in the text. Here, q(t) represents tracer concentration in compartment i, and CL(t) is the logarithmic average of Ci(t) and C2(t), defined below. The treatment of membrane transport of Kedem and Katchalsky (1961) , Perl (1973), and Perl (1975) leading to Equation A-26 holds only for ideal solutions or dilute real solutions. Jeffrey et al. (1977) show that solutions of ovalbumin behave nonideally at molar concentrations over ranges that include the value of the bovine-serum albumin concentration used in the perfusates. We discuss this point further below. In order to relax the constraint imposed by limitation to ideal solutions in the formulations of the above-mentioned authors, we replace their transmembrane difference of solute concentration by the difference of thermodynamic activity as the driving force for solute permeation across the membrane, and write, in place of Equation A-26, j d (t) = PS[a,(t) -a 2 (t)].
(A-28)
The thermodynamic activity is related to the solute concentration according to a;(t) = i = 1, 2, (A-29a, b) (Lewis and Randall, 1961) . Here, a;(t) is the activity in compartment i at time t, q(t) is the corresponding concentration, and y; is the activity coefficient. The latter depends on the total concentration of solute which, in the systemic steady state assumed to prevail in the heart preparations, remains unchanged within a compartment. In Equation A-27, CL(t) represents a mean solute concentration in a membrane channel through which convective transport of solute is taking place. Kedem and Katchalsky (1961) show that the appropriate mean is the logarithmic average
CL(t) = Cl(t) ~ C 2 (t)
In c,(t) -In c 2 (t)'
where the subscripts 1 and 2 refer to vascular and extravascular space concentrations, respectively. For Ci(t) -c 2 (t) <SC c 2 (t) < ci(t), the above logarithmic average is well approximated by the arithmetric average, so that In terms of these unidirectional fluxes, the net flux is = J2l(t) -jl (A-38)
We have thus expressed the resultant net albumin flux as a superposition of component fluxes in two different ways (Perl, 1975) : first, as a diffusive flux plus a solvent-drag convective flux as in Equation A-25, and, second, as the difference of two unidirectional fluxes as in Equation A-38. As pointed out by Perl (1975) , the negative contribution to the reverse flux, expressed as j, 2 (t) = [y 2 PS -fc(l -a)J v ]c 2 (t) (A-39) (obtained by combining Equations A-35 and A-37), represents solvent drag of radioalbumin from vascular to extravascular space proportional to c 2 (t); the effect is independent of the value of Ci(t) because it corresponds to an average concentration c 2 (t)/2 of the radioalbumin molecules within the membrane channel that are subject to the solvent-drag force. We note that an analogous interpretation is possible for the forward flux, j 2 i(t), for which the solvent-drag effect is positive; in this case, the average concentration of molecules subject to the drag force is Ci(t)/2, and is independent of c 2 (t). Because of this interpretation, we assign the name "ultrafiltration parameter" to the group '/2(1 -a)J v , noting that it is the convective analog of the diffusive group, PS, or "permeabilitycoefficient surface-area product"; both have dimensions of flow. We use the symbol, LJ, to denote the ultrafiltration parameter, and write U A -a)Jv.
(A-40)
In connection with the discussion in the text of our procedure of normalizing certain of our model parameters to a dry weight basis, we indicated that the permeability coefficient, P, is an intensive quantity; that is, its value is independent of the preparation size, as measured, for example, by the dry weight, W. This can readily be seen to be true by noting that the total diffusive radioalbumin flux, jd(t), is proportional to the total surface area, S, available for permeation. Thus, the ratio = jd(t)/S, (A-41)
or flux density, is independent of W, and so is an intensive quantity. On solving Equation A-28 for the permeability coefficient and combining the result with Equation A-39, we obtain P 4 -a 2 (t)];
this expression is, in fact, a definition of the permeability coefficient. The thermodynamic activities, ai(t), are intensive quantities, and since it is defined above as a ratio of intensive quantities, P itself must be an intensive quantity. Zierler (1965) has shown that the mean, I, of the distribution of transit times of tracer molecules through a flow system having a single convective inlet and a single convective outlet is given by the zeroeth moment of the dose-normalized residue function, i.e., "I q(t) dt/q 0 . (A-42)
Radioalbumin Mean Transit Time
In the above, q(t) is the residue function (Equation A-8), that is, the amount of tracer contained simultaneously in the detector field and in the flow system at time t following the beginning of administration of a total amount of tracer, qo, at the arterial inflow of the system. Because of the assumptions concerning the detection efficiency of our external radiotracer counting probe, discussed in connection with Equations A-16 to A-20, we see that the mean transit time relation of Equation A-42, given in terms of tracer quantities, can also be expressed for the present experiments in terms of count rates due to radiolabeled bovine serum albumin in the detector field in the form r tBSA = I Jo r(t)dt/r 0 .
(A-43)
In the following, we derive an expression for the mean transit time in terms of our model parameters, and show that this expression reduces to that of the Central Volume Principle (Kety, 1949; Zierler, 1965; Perl and Chinard, 1968; Perl, 1971; Roberts et al., 1973) only in the special case when diffusion is the sole transport mechanism for tracer between vascular and extravascular spaces. When solvent-drag transport of tracer occurs, our model predicts a mean transit time that can be numerically smaller than, equal to, or larger than that given by the Central Volume Principle, thus demonstrating that it may not be so universally applicable as is generally assumed. We now show why the mean transit time of radioalbumin in the present preparations can be numerically larger than that predicted by the Central Volume Principle. For the case of our two-compartment model, the Central Volume Principle can be written (Roberts et al., 1973) as tcvp = (Vi + AV 2 )/F.
(A-48)
Here, the partition coefficient is defined as the ratio of the concentration of systemic substance in compartment 2 to that in compartment 1 in the systemic steady state. An equivalent definition of the partition coefficient is that it is the ratio of the concentration of tracer in compartment 2 to that in compartment 1 in the tracer steady state, such as would be attained in the system at long times after the start of a constantconcentration infusion of tracer (Roberts et al., 1973) . In either case, the condition for establishment of a steady state is equality of the chemical potentials, or, equivalently, equality of the thermodynamic activities in the two compartments. Using an infinity subscript to denote the above-mentioned long times to attain steady state conditions in an infusion experiment, the tracer steady state can be represented by the condition aioo = a 2 oo, which, with Equations A-29, yields the evaluation Y2 (A-49)
On taking the limit of the right side of Equation A-46 as p approaches zero from positive or negative values, we find from Equations A-48 and A-49 that (A-50)
We see also from Equation A-46 that tssA > tcvp for lim tBSA = tcvp.
p-0±
all p such that 0 < p < 72, and that tesA is unbounded above as p -• * 72--Mathematically, Equation A-46 predicts t B sA < 0 when p > y 2 > 0; this apparent physiological contradiction is reconciled by noting that p > 72 > 0 implies k]2 < 0 through Equations A-35, A-37, and A-40. However, the tracer conservation conditions, Equation A-l, which are established through consideration of the intercompartmental unidirectional fluxes (Equations A-36 and A-37, are so written that these fluxes and the corresponding turnover-rate constants are restricted by definition to nonnegative values. According to this convention, then, the minimum value that k. 12 can take on is zero. The case p > 72 > 0 merely corresponds to the situation in which, for the reverse flux, the negative solvent-drag component dominates the positive diffusive component. Reference to Equation A-39 shows that ji2(t) would then be negative, but a negative reverse flux is the logical equivalent of a positive forward flux, and-in such a case-the actual reverse flux would be zero. Under these conditions, there would be permanent sequestration of radioalbumin in compartment 2 without back-diffusion, and the tracer mean transit time would have no upper limit, in agreement with Equation A-45 for the case when ki2 approaches its lower bound of zero.
We have thus shown that the Zierler, or measured mean transit time, t B sA, defined by Equation A-43 and given on our model by Equation A-45, is equivalent to the Central Volume Principle mean transit time, tcvp, given for the case of a two-compartment model by Equation A-48, only when there is no transport by solvent drag. Since we cannot, a priori, rule out occurrence of solvent-drag transport in our experiments, we cannot validly use the central volume expression, Equation A-48, to compute the extravascular albumin space, V2, from our measured perfusate flow, tracer mean transit time evaluated according to Equation A-44, and the vascular space computed using Equations A-21 and A-24. Instead, we apply an independent tracer-infusion technique, as described in the text, to obtain values of V2.
Thermodynamic Activity Coefficients and Partition Coefficient of Albumin
We were unable to find information in the literature concerning the measurement of thermodynamic activities and activity coefficients for bovine serum albumin (BSA) in aqueous solution. We refer, therefore, to the ultracentrifuge sedimentation equilibrium results of Jeffrey et al. (1977) for ovalbumin. The protein studied by these authors has a molecular weight of 45,000 g/mol, whereas that of BSA is 69,000 g/mol. However, the correlations given by Jeffrey et al. between the activity coefficient and the concentration are cast in terms of molar units over a range of values that includes that of our BSA perfusate. Moreover, the dependence of the activity coefficient on concentration is not pronounced, either at the ovalbumin isoelectric point at pH = 4.59, or for results obtained at pH = 7.5. For the latter condition, at ionic strength 0.1 and 20°C, the correlation found by Jeffrey et al. (1977) is In 7 = a(C/M) + /?(C/M) 2 , in which a = 1.49 X 10 3 liters/mol, /? = -2.1 X 10 6 Iiters 2 /mol 2 , and M is the molecular weight. For. our perfusate concentration of C = Ci = 1 weight percent = 10 g/liter, and with M = 69,000 g/mol, the above equation leads to 71 = 1.19. A measure of the relative sensitivity of the value of the activity coefficient to changes in albumin concentration is 7 dC Evaluated at C = Ci = 10 g/liter, the above yields the value 0.13. Thus, for example, a 10% change in concentration would lead to a change in 7 of only about 1.3% under the stated conditions. At the isoelectric point of ovalbumin, the corresponding results for C = Ci = 10 g/liter are 7 = 1.12 and dC 0.11.
Thus, it can be seen that the activity coefficient of ovalbumin at a molar concentration equal to that of BSA in the perfusate is relatively insensitive to changes both in protein concentration and in pH. We assume that the thermodynamic behavior of BSA is similar to that of ovalbumin, assigning the values 71 = 72 = 7" = 1.2 for our calculations that make use of Equations 13, 33, and 34 of the text. We note, on referring to Equation A-49, that the above considerations concerning albumin activity coefficients imply the value A = 1. Therefore, in the text we write the specific extravascular distribution volume, AV2, as V2.
